Welcome to ‘Between the Biotech Waves,’ the podcast where we navigate the dynamic world of biotechnology and explore the minds driving its innovation. I’m your host, Nessan Bermingham, and today, we have a true visionary in the field, Peter Barrett.
Peter is a partner at Atlas Venture, where he has been a key player in the creation of numerous novel therapeutic and drug discovery platform companies. With an unyielding passion for advancing healthcare, Peter has been directly involved in co-founding, building, investing and supporting numerous companies including Celera Genomics, Alynlam Therapeutics and Momenta, to name just a few.
Known for his entrepreneurial spirit, Peter co-founded Celera Genomics, where he led groundbreaking work that culminated in the first successful sequencing of the human genome in 2001. His strategic insights propelled Celera into the public arena, and his leadership has shaped the trajectory of many biotech companies over the years.
In addition to his roles in the biotech sector, Peter is an Executive Fellow at Harvard Business School and serves as the faculty chair of the advisory board for the prestigious Blavatnik Fellowship Program, helping to cultivate the next generation of leaders in science and business.
Join me as we engage in a fascinating conversation with Peter Barrett, delving into his remarkable journey, the evolution of biotechnology, and the innovative spirit that drives his work.